Delivery Order SPE2DB24D8003-SPE2DB25FJTPM

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,101.32 firm fixed price contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, that enables the company to provide...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the purchase of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a total ceiling value of $15,933.58 and a period of performance through November 18, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division under the ECAT...
This is a delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) for the procurement of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML pharmaceutical products. The contract has a ceiling value of $1,550.66 and a period of performance through December 16, 2024. It is a firm fixed-price contract, with no set-aside designation. Dakota Drug, Inc. is a key supplier to the DLA's Troop Support Medical division, providing a wide...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,286.46 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products. This contract, identified as SPE2DB24D8001, is part of the DLA Troop Support Medical's ECAT Generation V Program, which enables Dakota Drug, Inc. to provide a broad range of pharmaceutical and medical supplies to support U.S. Armed Forces medical operations. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products. The contract, identified as SPE2DB24D8001|SPE2DB25FKYZP, is a Firm Fixed Price Delivery Order with a ceiling value of $3,486.24 and a performance period through January 6, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The $3,563.88 award is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. This contract supports the DLA Troop Support Medical's mission of providing comprehensive medical supply chain operations for the U.S. Armed Forces. The...
This federal contract award, valued at $2,661.64, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of the pharmaceutical product "WEGOVY 0.5 MG/0.5 ML PEN 0.5ML" and has a performance period through November 8, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. This award is a delivery...
This is a firm fixed-price delivery order awarded by the U.S. Department of Defense's Medical Supply Chain organization (also known as the Defense Logistics Agency (DLA) Troop Support Medical) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $4,897.22 contract is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a prescription medication, with a performance period ending on April 25, 2024. The contract was awarded on...
This federal contract award, valued at $5,256.21, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a firm fixed-price delivery order for the pharmaceutical product "WEGOVY 1 MG/0.5 ML PEN 0.5ML". This award is part of a larger Indefinite Delivery Contract (IDC) between Dakota Drug, Inc. and the DLA Troop Support Medical's ECAT Generation V Program,...
Dakota Drug, Inc. has been awarded a firm fixed price delivery order valued at three thousand nine hundred fifty-four dollars and fifty-six cents ($3,954.56) by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical). This delivery order was issued against Dakota Drug's existing blanket purchase agreement with DLA Troop Support Medical and provides for the delivery of forty-five hundred sixty-three units of WEGOVY 2.4 MG/0.75 ML pens to Anoka, Minnesota by December 18,...
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB25FJTPM
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products. The contract has a firm fixed price pricing type, a ceiling value of $4,822.96, and a period of performance through January 7, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, holding a single-award Indefinite Delivery Contract valued at $999,999,999.00 as part of the DLA's ECAT Generation V Program. This delivery order contract is not set aside and was competitively awarded to Dakota Drug, Inc. to support U.S. Armed Forces medical operations by providing a range of pharmaceutical products and medical supplies.

Generated 4/7/25, 9:42 AM